514 related articles for article (PubMed ID: 29500241)
1. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
Osborne AJ; Breno M; Borsa NG; Bu F; Frémeaux-Bacchi V; Gale DP; van den Heuvel LP; Kavanagh D; Noris M; Pinto S; Rallapalli PM; Remuzzi G; Rodríguez de Cordoba S; Ruiz A; Smith RJH; Vieira-Martins P; Volokhina E; Wilson V; Goodship THJ; Perkins SJ
J Immunol; 2018 Apr; 200(7):2464-2478. PubMed ID: 29500241
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Protein Structural Evaluation of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
Perkins SJ
Adv Chronic Kidney Dis; 2020 Mar; 27(2):120-127.e4. PubMed ID: 32553244
[TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration.
Geerlings MJ; Volokhina EB; de Jong EK; van de Kar N; Pauper M; Hoyng CB; van den Heuvel LP; den Hollander AI
Clin Genet; 2018 Oct; 94(3-4):330-338. PubMed ID: 29888403
[TBL] [Abstract][Full Text] [Related]
4. Complement Factor I Variants in Complement-Mediated Renal Diseases.
Zhang Y; Goodfellow RX; Ghiringhelli Borsa N; Dunlop HC; Presti SA; Meyer NC; Shao D; Roberts SM; Jones MB; Pitcher GR; Taylor AO; Nester CM; Smith RJH
Front Immunol; 2022; 13():866330. PubMed ID: 35619721
[TBL] [Abstract][Full Text] [Related]
5. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
Front Immunol; 2019; 10():853. PubMed ID: 31118930
[TBL] [Abstract][Full Text] [Related]
6. Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD.
Wong EKS; Hallam TM; Brocklebank V; Walsh PR; Smith-Jackson K; Shuttleworth VG; Cox TE; Anderson HE; Barlow PN; Marchbank KJ; Harris CL; Kavanagh D
Front Immunol; 2020; 11():602284. PubMed ID: 33519811
[TBL] [Abstract][Full Text] [Related]
7.
Zipfel PF; Wiech T; Stea ED; Skerka C
J Am Soc Nephrol; 2020 Feb; 31(2):241-256. PubMed ID: 31980588
[TBL] [Abstract][Full Text] [Related]
8. A haplotype in CFH family genes confers high risk of rare glomerular nephropathies.
Ding Y; Zhao W; Zhang T; Qiang H; Lu J; Su X; Wen S; Xu F; Zhang M; Zhang H; Zeng C; Liu Z; Chen H
Sci Rep; 2017 Jul; 7(1):6004. PubMed ID: 28729648
[TBL] [Abstract][Full Text] [Related]
9. Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome.
Yun JW; Oh J; Lee KO; Lee SJ; Kim JO; Kim NK; Kim JS; Koh Y; Yoon SS; Yhim HY; Jo SK; Park Y; Lee JE; Park J; Lee JW; Kim SH; Kim HJ; Oh D; ;
Thromb Res; 2020 Oct; 194():45-53. PubMed ID: 33213850
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
Szarvas N; Szilágyi Á; Csuka D; Takács B; Rusai K; Müller T; Arbeiter K; Réti M; Haris Á; Wagner L; Török S; Kelen K; Szabó AJ; Reusz GS; Morgan BP; Prohászka Z
Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
[TBL] [Abstract][Full Text] [Related]
11. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.
Togarsimalemath SK; Sethi SK; Duggal R; Le Quintrec M; Jha P; Daniel R; Gonnet F; Bansal S; Roumenina LT; Fremeaux-Bacchi V; Kher V; Dragon-Durey MA
Kidney Int; 2017 Oct; 92(4):876-887. PubMed ID: 28729035
[TBL] [Abstract][Full Text] [Related]
12. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
Martínez-Barricarte R; Heurich M; López-Perrote A; Tortajada A; Pinto S; López-Trascasa M; Sánchez-Corral P; Morgan BP; Llorca O; Harris CL; Rodríguez de Córdoba S
Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
[TBL] [Abstract][Full Text] [Related]
13. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
Maga TK; Nishimura CJ; Weaver AE; Frees KL; Smith RJ
Hum Mutat; 2010 Jun; 31(6):E1445-60. PubMed ID: 20513133
[TBL] [Abstract][Full Text] [Related]
14. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.
Iatropoulos P; Noris M; Mele C; Piras R; Valoti E; Bresin E; Curreri M; Mondo E; Zito A; Gamba S; Bettoni S; Murer L; Fremeaux-Bacchi V; Vivarelli M; Emma F; Daina E; Remuzzi G
Mol Immunol; 2016 Mar; 71():131-142. PubMed ID: 26895476
[TBL] [Abstract][Full Text] [Related]
15. Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome.
Bu F; Zhang Y; Wang K; Borsa NG; Jones MB; Taylor AO; Takanami E; Meyer NC; Frees K; Thomas CP; Nester C; Smith RJH
J Am Soc Nephrol; 2018 Dec; 29(12):2809-2819. PubMed ID: 30377230
[TBL] [Abstract][Full Text] [Related]
16. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
[TBL] [Abstract][Full Text] [Related]
17. Complete functional characterization of disease-associated genetic variants in the complement factor H gene.
Merinero HM; García SP; García-Fernández J; Arjona E; Tortajada A; Rodríguez de Córdoba S
Kidney Int; 2018 Feb; 93(2):470-481. PubMed ID: 28941939
[TBL] [Abstract][Full Text] [Related]
18. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
Moore I; Strain L; Pappworth I; Kavanagh D; Barlow PN; Herbert AP; Schmidt CQ; Staniforth SJ; Holmes LV; Ward R; Morgan L; Goodship TH; Marchbank KJ
Blood; 2010 Jan; 115(2):379-87. PubMed ID: 19861685
[TBL] [Abstract][Full Text] [Related]
19. Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.
Westra D; Volokhina EB; van der Molen RG; van der Velden TJ; Jeronimus-Klaasen A; Goertz J; Gracchi V; Dorresteijn EM; Bouts AH; Keijzer-Veen MG; van Wijk JA; Bakker JA; Roos A; van den Heuvel LP; van de Kar NC
Pediatr Nephrol; 2017 Feb; 32(2):297-309. PubMed ID: 27718086
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
